Skip to main content

Table 1 Patients’ main characteristics

From: Kinetics of blood neutrophil and lymphocyte count in critically ill neutropenic patients with hematological malignancies

 

Patients (n = 210)

Male gender, n (%)

124 (59%)

Age (years)

61 (47–67)

Hematological malignancy, n (%)

 Acute leukemia

139 (66%)

 Non-Hodgkin lymphoma

41 (20%)

 Hodgkin lymphoma

5 (2%)

 Multiple myeloma

14 (7%)

 Other

11 (5%)

Laboratory on ICU admission

 Neutrophil count, × 109/L

0.06 (0.02–0.28)

 Lymphocyte count, × 109/L

0.14 (0.04–0.42)

 White blood cell count, × 109/L

0.34 (0.07–1.16)

 Platelet count, × 109/L

24 (13–43)

 Hemoglobin, g/dL

7.9 (7.1–8.8)

 Creatinine, mg/dL

1.13 (0.75–1.61)

 HCO3−, mmol/L

22 (19–26)

 Lactate, mmol/L (n = 117)

1.8 (1.2–3.4)

Vital organ support in the ICU

 Vasopressors, n (%)

92 (44%)

 Mechanical ventilation, n (%)

88 (42%)

 Renal replacement therapy, n (%)

17 (8%)

Hospital mortality, n (%)

83 (40%)

  1. Results are presented as median (interquartile range) and number (percentage) for continuous and categorical variables, respectively